Several Web 2.0 startups, however, have managed to get venture capital in the foreign markets and underatken studies to understand the market potential of Web 2.0 sites.
The company has entered into exclusive tie-ups with the US-based PopCap Games, Playfirst, and Russian game developer and distributor, Alawar, to provide content for casual (not the high-end ones) games.
Five global engineering and power equipment construction majors are in the race to bag the Rs 8,000 crore
The list, posted on a website link launched by the US regulator, includes ABB, HSBC, Nokia, Unilever, Cadbury, Total and Siemens among others.
The US Food and Drug Administration has tightened rules for selling dietary supplements in the US market, making compliance with current good manufacturing practices mandatory for manufacturers.
Indian drug major Nicholas Piramal India Ltd is likely to be among the first pharmaceutical companies worldwide to develop drugs isolated from the flora and fauna of Antarctica.
Part research being farmed out to medical colleges, universities to cut cost and time.
TCS, NXP Semiconductors and Gemini Traze are already in the fray.
Game developers are increasingly eyeing Bollywood production houses to create content.
These brands belong to about 320 drugs of leading Indian pharmaceutical companies. The Drug Controller General of India's (DCGI's) office feels that these have been launched without its approval.
The 550,000 unorganised drug traders in the country are readying to take on the entry of corporate houses like Anil Dhirubhai Ambani Group
RPG Life already has marketing tie-ups with Israel's drug major Teva for the EU market and with the US-based Apotex for the Canadian market.
The average expenditure of pharmaceutical companies on research and development has increased four times in the last five years.
Swiss pharmaceutical major Hoffmann-La Roche's patents rights over Hepatitis C drug Pegasys has been challenged by public interest groups at the Indian Patent Office.
The first off the block appears to be the Reliance Anil Dhirubhai Ambani Group (R-ADAG), which is investing Rs 1,200 crore (Rs 12 billion) in setting up a large drug distribution backbone.
The six-decade-old pharmaceutical company VHB Life Sciences will come out with an initial public offer in July this year to fund its Rs 400-crore
Alkem, the largest manufacturer of Fructo-Oligo Saccharides, which helps the growth of good probiotic bacteria, is planning to roll out more products in the national and global markets, said Sharad.
Reliance Pharmaceuticals, the proposed pharmaceutical manufacturing company promoted by Mukesh Ambani's Reliance Life Sciences, will soon rope in a consultant to give final shape to the project, slated to take off within two years.
Nareshchandra Singh, an IT analyst with global research and analyst firm Gartner, takes only a few seconds to reach his office from home.
Future Group, the Rs 2,000-crore (Rs 20-billion) Indian retail giant, is set to invest close to Rs 400 crore (Rs 4 billion) over a period of three years to revamp its IT infrastructure.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances